The findings add to a growing body of evidence that the shingles vaccine may help keep dementia at bay – but researchers still need to prove it. View on euronews ...

It's only a week since Rachel Reeves unveiled her Spring Statement but her plan to balance the nation's books looks set to ...

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the successful conclusion of the eleventh Annual Genedata Partner Symposium (March 31?April 1 ...

A major British investor is exploring a potential rescue plan for 23andMe, after the consumer genetics company filed for ...

Wave Life Sciences Ltd.’s WVE share price has dipped by 10.08%, which has investors questioning if this is right time to buy.

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...

AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Taiho Pharmaceutical is paying $400 million to ...

Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for the deal ...

GSK's vaccine against respiratory syncytial virus (RSV) is one of the top prospects in its pipeline, but also one with considerable competition, so needs strong data to support the programme.

Larson Financial Group LLC cut its holdings in GSK plc (NYSE:GSK – Free Report) by 52.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission.

8-10 Dr Lee Tau Hong, Infectious Disease Specialist, Infectious Diseases Care Clinic in Singapore, shared with GSK, "RSV poses a significant burden on patients, families, and healthcare systems ...